Sulfation of α-hydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts

被引:91
作者
Shibutani, S [1 ]
Shaw, PM
Suzuki, N
Dasaradhi, L
Duffel, MW
Terashima, I
机构
[1] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA
[2] PanVera Corp, Madison, WI 53711 USA
[3] Univ Iowa, Coll Pharm, Div Med & Nat Prod Chem, Iowa City, IA 52242 USA
关键词
D O I
10.1093/carcin/19.11.2007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The formation of tamoxifen (TAM)-derived DNA adducts was investigated by incubation of DNA with (E)-alpha-hydroxy-tamoxifen [(E)-alpha-OHTAM], 3'-phosphoadenosine 5'-phosphosulfate (PAPS), and human recombinant sulfotransferase, Using P-32-post-labeling and HPLC analysis, two TAM-DNA adducts were detected in incubations that included the human hydroxysteroid sulfotransferase SULT2A1 (hHST), When compared with standards of stereoisomers of alpha-(N"-deoxyguanosinyl)tamoxifen 3'-monophosphate (dG(3,P)-N-2-TAM), the major adduct was identified chromatographically as an epimer of the transform of dG-N-2-TAM, and the minor adduct was identified as an epimer of the cis-form, The amount of TAM adducts formed by hHST was approximately three times less than that formed by an equivalent amount of rat hydroxysteroid (alcohol) sulfotransferase a. These results indicate that sulfation of alpha-OHTAM catalyzed by hHST results in the formation of dG-N-2-TAMs, highly miscoding lesions, in human tissues.
引用
收藏
页码:2007 / 2011
页数:5
相关论文
共 32 条
[1]  
Carmichael PL, 1996, CANCER RES, V56, P1475
[2]   Influence of substrate structure on the catalytic efficiency of hydroxysteroid sulfotransferase STa in the sulfation of alcohols [J].
Chen, GP ;
Banoglu, E ;
Duffel, MW .
CHEMICAL RESEARCH IN TOXICOLOGY, 1996, 9 (01) :67-74
[3]   Identification of tamoxifen-DNA adducts formed by alpha-sulfate tamoxifen and alpha-acetoxytamoxifen [J].
Dasaradhi, L ;
Shibutani, S .
CHEMICAL RESEARCH IN TOXICOLOGY, 1997, 10 (02) :189-196
[4]  
Davies R, 1997, CANCER RES, V57, P1288
[5]  
FISCHER B, 1994, J NATL CANCER I, V86, P527
[6]   HYDROXY DERIVATIVES OF TAMOXIFEN [J].
FOSTER, AB ;
JARMAN, M ;
LEUNG, OT ;
MCCAGUE, R ;
LECLERCQ, G ;
DEVLEESCHOUWER, N .
JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (10) :1491-1497
[7]  
GLATT H, 1995, EUR J PHARM-ENVIRON, V293, P173, DOI 10.1016/S0014-2999(05)80010-X
[8]  
GREAVES P, 1993, CANCER RES, V53, P3919
[9]  
HAN XL, 1992, CANCER RES, V52, P1360
[10]  
HARD GC, 1993, CANCER RES, V53, P4534